Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

The importance of AI in improving patient care

Looking at the ways healthcare technology creates the capacity to improve collaboration, increase efficiency and optimise patient care

- PMLiVE

Medscape Education Global Delivers Education and Outcomes to ECCMID 2023

Medscape Education Global has wrapped up its time in Copenhagen at ECCMID 2023. During the conference, Medscape Education Global had the opportunity to engage learners with an educational symposium and...

Medscape Education

Antithrombotic Therapy for Peripheral Artery Disease: Medscape Education and Outcomes

At this year’s ACC2023 event, the Medscape Education team shared 7 posters highlighting the outcomes of cardiology continuing medical education (CME) programs. These posters covered a variety of cardiology topics...

Medscape Education

- PMLiVE

GSK to acquire Bellus Health for approximately $2bn

The deal includes the biotech’s late-stage candidate for refractory chronic cough

- PMLiVE

FDA approves Gamida’s cell therapy for blood cancer patients

Blood cancers represent about 10% of all annual US cancer cases

- PMLiVE

Authorisation for Moderna and Pfizer/BioNTech’s bivalent COVID-19 vaccines simplified by FDA

The vaccines are now authorised for all doses in individuals aged six months and older

- PMLiVE

Tiziana to develop intranasal foralumab for type 1 diabetes

Approximately 4.7 million people in the UK are currently living with diabetes

- PMLiVE

Four simple questions to help focus your behaviour change campaigns

By Samuel Hughes and Edward Brightman

- PMLiVE

Global healthcare consultancy Uptake Strategies unveils a newly refreshed identity

Uptake, formerly known as Uptake Strategies, has revealed a bold brand refresh for its 18th year

- PMLiVE

AstraZeneca presents positive phase 3 results for Imfinzi regimen in lung cancer

Around 2.2 million people are diagnosed with lung cancer globally each year

- PMLiVE

Gilead’s COVID-19 treatment shows promising results in vulnerable patient populations

Veklury demonstrated a reduction in mortality and hospital readmission rates

- PMLiVE

Roche reports positive phase 3 data for Tecentriq combination in liver cancer

More than 900,000 people are diagnosed with the disease globally each year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links